Barclays’s Arotech Corporation ARTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-6,616
Closed -$19K 7515
2019
Q1
$19K Sell
6,616
-191
-3% -$610 ﹤0.01% 6385
2018
Q4
$18K Buy
6,807
+5,304
+353% +$14.8K ﹤0.01% 5965
2018
Q3
$5K Sell
1,503
-3,193
-68% -$11.4K ﹤0.01% 6810
2018
Q2
$18K Sell
4,696
-5,018
-52% -$17.9K ﹤0.01% 6256
2018
Q1
$30K Sell
9,714
-3,886
-29% -$13.3K ﹤0.01% 6254
2017
Q4
$48K Sell
13,600
-42
-0.3% -$162 ﹤0.01% 5792
2017
Q3
$57K Buy
13,642
+9,580
+236% +$34.6K ﹤0.01% 5292
2017
Q2
$14K Buy
+4,062
New +$13.4K ﹤0.01% 5947

Other funds holding ARTX

Barclays's ARTX Position: Q2 2019 in Review

Barclays sold out of Arotech Corporation (ARTX) in Q2 2019, closing a stake of 6,616 shares — an estimated $19K sold.

Barclays first reported a position in ARTX in Q2 2017 and held it in 8 quarters. The position peaked at $57K in Q3 2017. 51 funds tracked by Wall St. Rank hold ARTX as of Q2 2019.

  • Barclays reported no remaining Arotech Corporation position as of Q2 2019 after selling out during the quarter.
  • Barclays sold 6,616 Arotech Corporation shares in Q2 2019, an estimated $19K.
  • Barclays first reported a position in Arotech Corporation in Q2 2017 and held it in 8 quarters.
  • Barclays's Arotech Corporation position peaked at $57K in Q3 2017.
  • 51 funds tracked by Wall St. Rank held Arotech Corporation as of Q2 2019.

Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.